(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -31.27%68.15B | -30.44%45.57B | -32.08%21.33B | 6.80%141B | 16.21%99.16B | 16.40%65.5B | 23.32%31.4B | -21.40%132.02B | -29.89%85.33B | -30.06%56.28B |
Operating income | -31.27%68.15B | -30.44%45.57B | -32.08%21.33B | 6.80%141B | 16.21%99.16B | 16.40%65.5B | 23.32%31.4B | -21.40%132.02B | -29.89%85.33B | -30.06%56.28B |
Cost of sales | ---- | 29.80%-37.39B | ---- | -13.17%-118.63B | ---- | -30.92%-53.27B | ---- | 12.20%-104.83B | ---- | 31.07%-40.69B |
Operating expenses | 32.27%-54.83B | 29.80%-37.39B | 33.07%-17.54B | -13.17%-118.63B | -27.13%-80.96B | -30.92%-53.27B | -49.95%-26.21B | 12.20%-104.83B | 28.21%-63.68B | 31.07%-40.69B |
Gross profit | -26.81%13.32B | -33.21%8.17B | -27.11%3.79B | -17.75%22.36B | -15.92%18.2B | -21.50%12.23B | -34.98%5.19B | -44.01%27.19B | -34.42%21.64B | -27.27%15.59B |
Selling expenses | 7.96%-2.33B | 3.92%-1.56B | 8.33%-718.42M | -2.89%-3.42B | -9.39%-2.54B | -6.76%-1.63B | -15.42%-783.69M | 2.38%-3.33B | 6.99%-2.32B | 2.94%-1.53B |
Administrative expenses | 5.52%-4.29B | 10.28%-2.57B | 8.81%-1.35B | -0.55%-5.41B | -18.71%-4.54B | -10.36%-2.87B | -14.56%-1.48B | -5.43%-5.38B | -16.24%-3.82B | -11.72%-2.6B |
Research and development expenses | 34.02%-865.02M | 29.24%-519.22M | 29.98%-185.76M | 7.55%-1.86B | 8.41%-1.31B | 10.02%-733.75M | -7.83%-265.3M | -51.54%-2.01B | -178.52%-1.43B | -195.64%-815.48M |
Profit from asset sales | -123.93%-9.47M | ---- | -212.09%-127.42K | ---- | 930.80%39.6M | ---- | -97.49%113.67K | ---- | -92.77%3.84M | ---- |
Revaluation surplus | 12.62%-73.95M | ---- | -118.75%-20.96M | ---- | 77.14%-84.63M | ---- | -1.31%111.74M | ---- | -249.96%-370.14M | ---- |
-Changes in the fair value of other assets | 12.62%-73.95M | ---- | -118.75%-20.96M | ---- | 77.14%-84.63M | ---- | -1.31%111.74M | ---- | -249.96%-370.14M | ---- |
Impairment and provision | 34.88%-18.57M | ---- | 86.15%-710.01K | -21,182.33%-333.71M | 14.15%-28.51M | ---- | -22.91%-5.13M | ---1.57M | -1,876.10%-33.21M | ---- |
-Other impairment is provision | 34.88%-18.57M | ---- | 86.15%-710.01K | -21,182.33%-333.71M | 14.15%-28.51M | ---- | -22.91%-5.13M | ---1.57M | -1,876.10%-33.21M | ---- |
Special items of operating profit | -37.44%622.01M | -35.57%1.24B | -28.81%139M | -12.69%3.17B | -30.41%994.26M | -16.49%1.92B | -49.49%195.24M | -28.92%3.63B | -23.41%1.43B | -6.74%2.3B |
Operating profit | -43.12%5.67B | -46.76%4.75B | -46.44%1.45B | -27.83%14.5B | -30.77%9.97B | -31.06%8.93B | -55.16%2.71B | -54.15%20.09B | -48.54%14.4B | -34.36%12.95B |
Financing cost | -28.29%721.64M | 3.03%-403M | -10.19%254.65M | -77.34%-930.4M | -30.19%1.01B | -71.83%-415.61M | -25.15%283.55M | -57.23%-524.63M | 47.23%1.44B | -22.22%-241.87M |
Share of profits of associates | ---- | -23.08%152.63M | ---- | -55.59%178.79M | ---- | -9.97%198.43M | ---- | 4.49%402.63M | ---- | -6.19%220.4M |
Share of profit from joint venture company | ---- | -55.81%47.67M | ---- | -53.40%122.27M | ---- | -42.50%107.89M | ---- | -3.81%262.38M | ---- | 34.35%187.61M |
Special items of earning before tax | -10.84%411.33M | ---- | -50.92%207.54M | ---- | -7.35%461.35M | ---- | 69.31%422.87M | ---- | -34.75%497.98M | ---- |
Earning before tax | -40.51%6.8B | -48.39%4.55B | -43.99%1.92B | -31.45%13.87B | -30.01%11.44B | -32.76%8.82B | -48.80%3.42B | -54.17%20.23B | -45.03%16.34B | -34.11%13.11B |
Tax | 34.09%-1.56B | 40.82%-1B | 42.77%-427.81M | 26.41%-2.85B | 33.99%-2.36B | 39.77%-1.7B | 52.60%-747.49M | 61.06%-3.87B | 46.97%-3.58B | 37.47%-2.81B |
After-tax profit from continuing operations | -42.19%5.25B | -50.20%3.55B | -44.33%1.49B | -32.64%11.02B | -28.89%9.07B | -30.85%7.12B | -47.63%2.67B | -52.17%16.36B | -44.46%12.76B | -33.12%10.3B |
Earning after tax | -42.19%5.25B | -50.20%3.55B | -44.33%1.49B | -32.64%11.02B | -28.89%9.07B | -30.85%7.12B | -47.63%2.67B | -52.17%16.36B | -44.46%12.76B | -33.12%10.3B |
Minority profit | -88.38%46.56M | -83.54%60.95M | -112.03%-14.44M | -33.67%329.51M | 18.00%400.67M | 12.21%370.2M | -33.06%120.07M | -44.72%496.8M | -41.53%339.56M | -21.04%329.91M |
Profit attributable to shareholders | -40.05%5.2B | -48.37%3.49B | -41.14%1.5B | -32.61%10.69B | -30.17%8.67B | -32.28%6.75B | -48.16%2.55B | -52.37%15.86B | -44.53%12.42B | -33.46%9.97B |
Basic earnings per share | -39.63%0.99 | -48.03%0.66 | -41.67%0.28 | -32.44%2.02 | -29.91%1.64 | -32.45%1.27 | -48.39%0.48 | -52.39%2.99 | -44.55%2.34 | -33.57%1.88 |
Diluted earnings per share | -39.63%0.99 | -48.03%0.66 | -41.67%0.28 | -32.44%2.02 | -29.91%1.64 | -32.45%1.27 | -48.39%0.48 | -52.39%2.99 | -44.55%2.34 | -33.57%1.88 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data